- Revenue 2024
- $309,639
- Expenses 2024
- $331,784
Program services were 80.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- H30
- Classification
- 2000
- Street
- PO BOX 232
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2024
Mission
TO EMPOWER ANAL CANCER PATIENTS AND ACCELERATE PREVENTION AND RESEARCH METHODS THAT ELIMINATE ANAL CANCER AND THE VIRUS THAT CAUSES THE MAJORITY OF CASES, HPV.
Activities or mission (Part I)
TO EMPOWER ANAL CANCER PATIENTS AND ACCELERATE PREVENTION AND RESEARCH METHODS THAT ELIMINATE ANAL CANCER AND THE VIRUS THAT CAUSES THE MAJORITY OF CASES, HUMAN PAPILLOMAVIRUS (HPV).
-
EDUCATION: HPVACF EDUCATES THE GENERAL PUBLIC AND MEDICAL COMMUNITY ABOUT THE HUMAN PAPILLOMAVIRUS (HPV) AND THE CANCERS IT CAUSES. HPVACF INCREASES ACCESS TO, AND AWARENESS OF, PREVENTING HPV-RELATED CANCERS THROUGH CANCER PREVENTING SCREENING AND VACCINATION. THE ORGANIZATION RAISES AWARENESS AND DISSEMINATES INFORMATION THROUGH A VARIETY OF METHODS, INCLUDING PUBLIC PLATFORMS, FORUMS, ATHLETIC EVENTS AND PARTNERSHIPS.
Expenses $158,333 · Grants $34,546 · Revenue $9,127
-
PATIENT: HPVACF PROVIDES ROBUST RESOURCES, INFORMATION AND COMMUNITY INITIATIVES TO ANAL CANCER PATIENTS AND CAREGIVERS. HPVACF EDUCATIONAL AND COMMUNITY FORUMS BRING PATIENTS, CAREGIVERS AND PROVIDERS TOGETHER TO EMPOWER EACH OTHER AND BECOME INFORMED. TO ADDRESS ISOLATION IN THE COMMUNITY, HPVACF ESTABLISHED THE FIRST FORMAL ANAL CANCER PEER-PEER SUPPORT PROGRAM THAT MATCHES THRIVERS AND CAREGIVERS WITH PEERS WHO HAVE EXPERIENCED ANAL CANCER.
Expenses $96,081
-
RESEARCH: HPVACF PROVIDES FUNDING TO ACCELERATE NEW, EFFECTIVE DRUGS TO TREAT HPV-RELATED CANCERS, INCLUDING ANAL CANCER, AND TO BUILD THE SCIENTIFIC/MEDICAL INFRASTRUCTURE TO CREATE BETTER TREATMENT AND PREVENTION METHODS. THIS PROGRAM HAS CREATED THE FIRST ANAL NEOPLASIA MEDICAL SOCIETY, AND FUNDED GROUND-BREAKING RESEARCH TO FIND A CURE FOR ANAL CANCER AND HPV-RELATED CANCERS, ESPECIALLY IN THE FIELD OF IMMUNOTHERAPY.
Expenses $11,230
As filed on the 2024 return.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Tristan AlmadaTRISTAN ALMADA
PRESIDENT
- Total calculated
- $0
- Hours/week
- 5
-
Camille AlmadaCAMILLE ALMADA
VICE PRESIDENT & TREASURER
- Total calculated
- $0
- Hours/week
- 5
-
Christian LevettCHRISTIAN LEVETT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Justine X AlmadaJUSTINE X ALMADA
EXECUTIVE DIRECTOR
- Total calculated
- $61,165
- From this org
- $49,012
- From related orgs
- $0
- Other
- $12,153
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $309,639
- Expenses
- $331,784
- Contributions
- $294,381
- Grants paid
- $34,546
-
2023
- Revenue
- $922,329
- Expenses
- $393,850
- Contributions
- $905,130
- Grants paid
- $29,178
-
2022
- Revenue
- $263,974
- Expenses
- $396,446
- Contributions
- $248,021
- Grants paid
- $30,565
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $299,284
- Expenses
- $373,697
- Assets (EOY)
- $595,078
-
2020 · 990
- Revenue
- $264,444
- Expenses
- $303,413
- Assets (EOY)
- $651,230
-
2019 · 990
- Revenue
- $640,984
- Expenses
- $266,915
- Assets (EOY)
- $646,994
-
2018 · 990
- Revenue
- $60,295
- Expenses
- $234,547
- Assets (EOY)
- $328,657
-
2017 · 990
- Revenue
- $433,272
- Expenses
- $213,749
- Assets (EOY)
- $438,851
-
2016 · 990
- Revenue
- $48,260
- Expenses
- $243,922
- Assets (EOY)
- $226,438
-
2015 · 990
- Revenue
- $333,871
- Expenses
- $359,854
- Assets (EOY)
- $478,098
-
2014 · 990
- Revenue
- $251,762
- Expenses
- $556,788
- Assets (EOY)
- $534,938
-
2013 · 990
- Revenue
- $653,957
- Expenses
- $112,401
- Assets (EOY)
- $757,813
-
2012 · 990-EZ
- Revenue
- $138,079
- Expenses
- $70,225
- Assets (EOY)
- $212,425
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
-
2022 PATIENT EDUCATION: ANAL CANCER PATIENT TREATMENT GUIDE.
Grants received
-
2022 MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
-
2023 MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
-
2024 MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
-
$17,266
2024 GENERAL SUPPORT
-
2022 For grant recipient's exempt purposes
-
DONOR ADVISED CHARITABLE GIVING
$10,500
2024 HEALTH
-
DONOR ADVISED CHARITABLE GIVING
$10,000
2023 HEALTH
Taxable family
From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.
Disregarded entities on its 2024 return
-
HPV & ANAL CANCER FOUNDATION LIMITED LLC
TO EXECUTE ORGANIZATION'S MISSION IN UK · UK
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 1 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.